Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Remote Dielectric Sensing (ReDS) Assisted Diuresis in Acute Decompensated Heart Failure

NCT: NCT03586336 · RECRUITING

NCT IDNCT03586336
StatusRECRUITING
Start Date2018-12-01
Completion2027-12-31
SponsorUniversity of California, San Francisco (OTHER)
First posted
Last updated

Brief Summary

This study evaluates the use of a wearable vest capable of non-invasively measuring lung fluid content in hospitalized patients with heart failure

Frequently Asked Questions

What is Remote Dielectric Sensing (ReDS) Assisted Diuresis in Acute Decompensated Heart Failure?

Remote Dielectric Sensing (ReDS) Assisted Diuresis in Acute Decompensated Heart Failure is a clinical trial registered under NCT03586336. Current status: RECRUITING.

What is the status of NCT03586336?

The current status of NCT03586336 (Remote Dielectric Sensing (ReDS) Assisted Diuresis in Acute Decompensated Heart Failure) is: RECRUITING.

When did Remote Dielectric Sensing (ReDS) Assisted Diuresis in Acute Decompensated Heart Failure start?

Remote Dielectric Sensing (ReDS) Assisted Diuresis in Acute Decompensated Heart Failure started on 2018-12-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑